Breaking News

PPD, Science 37 Partner to Advance Decentralized Trials

PPD will leverage Science 37's DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PPD, Inc., a global CRO, and Science 37, developer of the Decentralized Clinical Trial Operating System (DCT OS), entered a collaboration in which PPD will leverage Science 37’s DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.   The extended agreement will enable PPD Digital to utilize Science 37’s configurable, SaaS-based DCT technology platform to design and implement Remote eConsent, eCOA, eSource and fully decentralized trials, as...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters